Toll like receptor (TLR) activation of basophils from patients with IgG4-RD led to release of B-cell-activating factor (BAFF) and IL-13, enhancing IgG4 production by B-cells from healthy controls (67). Here, TNFSF13B is linked to immunoglobulin G4-related sclerosing disease.